Latest 13F institutional holdings

Finward Bancorp has submitted its quarterly 13F filing, detailing a diverse portfolio of equity holdings valued at over $125 million as of March 31, 2026.

Tompkins Financial Corp filed its quarterly 13F holdings report for Q1 2026, detailing a diverse portfolio of 746 holdings valued at over $1.25 billion.

Orrstown Financial Services Inc. filed its quarterly 13F holdings report for the period ending March 31, 2026, detailing a portfolio valued at $597,476,809.

First Financial Corp. filed its quarterly 13F holdings report for the period ending March 31, 2026, detailing a diverse portfolio of 413 equity holdings valued at over $254 million.

Marex Group plc reported a diverse $4.38 billion investment portfolio for the quarter ended September 30, 2024, featuring significant institutional exposure to Bitcoin ETFs and high-growth technology stocks.

Marex Group plc discloses its institutional investment holdings for the quarter ended March 31, 2024.

Marex Group plc discloses its institutional investment holdings as of December 31, 2023, reporting a total portfolio value of approximately $2.54 billion.

Marex Group discloses its institutional investment portfolio as of September 30, 2023, featuring a diverse range of equity and ETF holdings.

Marex Group plc discloses its institutional investment holdings as of December 31, 2024, totaling approximately $5.87 billion in managed assets.

Marex Group plc discloses its institutional investment holdings as of March 31, 2025, reporting a total portfolio value of approximately $5.22 billion.

Marex Group plc discloses its institutional investment holdings as of June 30, 2023, totaling approximately $554.5 million.

Marex Group plc discloses its institutional investment holdings as of March 31, 2023, totaling approximately $755.26 million in assets.

Marex Group plc discloses its institutional investment holdings as of June 30, 2024, featuring a diverse portfolio of equities, ETFs, and derivatives.

Marex Group plc discloses its institutional investment holdings as of December 31, 2022, totaling over $703 million in assets.

Royalty Pharma plc filed a 13F-NT notice for the quarter ended December 31, 2025, indicating its holdings are reported by a sub-manager.

Barclays PLC filed an amended 13F report, correcting its Q3 2025 holdings to reflect a $461.23 billion portfolio across 11,877 positions.

Barclays PLC has filed an amendment to its Q3 2024 13F-HR report, restating holdings to reflect exact dollar values instead of thousands.

Barclays PLC has filed an amendment to its Q1 2023 13F report, correcting previously reported holding values from thousands to exact dollar amounts without changing positions.

Barclays PLC has filed an amendment to its Q2 2023 13F report, restating holding values from thousands to exact dollar amounts without changing positions.

Barclays PLC has filed an amended Form 13F-HR for Q4 2022, restating its reported holdings values from thousands to exact dollar amounts, with no changes to underlying positions.

Goldman Sachs Group Inc. filed an amended Form 13F-HR/A to correct and add securities holdings for the quarter ended December 31, 2025.

Barclays PLC has filed an amended 13F report for Q4 2023 to correct previously reported holding values from thousands to exact dollar amounts, with no changes to positions.

Barclays PLC has filed an amended 13F report for Q1 2024 to correct previously reported holdings values from thousands to exact dollar amounts, with no changes to underlying positions.

Barclays PLC has filed an amended 13F-HR report for Q2 2024 to correct previously reported holdings values from thousands to exact dollar amounts.

Barclays PLC has filed an amended 13F report for Q3 2025, restating holdings to reflect exact dollar values previously reported in thousands.

Barclays PLC has filed an amended Form 13F-HR/A for Q4 2024 to correct previously reported holdings values from thousands to exact dollar amounts.

Johnson & Johnson filed an amended 13F-HR report, restating its equity holdings for the quarter ended December 31, 2025, totaling $555 million.

Johnson & Johnson filed an amended 13F report, restating its institutional investment holdings totaling over $503 million for the quarter ended September 30, 2025.

Barclays PLC has filed an amendment to its Q1 2025 13F-HR report to correct previously misreported holding values from thousands to exact dollar amounts, ensuring compliance.

Banco Santander S.A. has filed an amended 13F report, revealing a previously confidential holding of 92,975 shares in Oatly Group AB valued at $1,103,613.